Hookipa Pharma announced updated phase 2 clinical data at the 2024 Annual Meeting of the American Society of Clinical Oncology in the United States.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.